suberoyl bis-hydroxamic acid has been researched along with Carcinoma, Epidermoid in 1 studies
suberoyl bis-hydroxamic acid: antineoplastic, Histone Deacetylase inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chikamatsu, K | 1 |
| Ishii, H | 1 |
| Murata, T | 1 |
| Sakakura, K | 1 |
| Shino, M | 1 |
| Toyoda, M | 1 |
| Takahashi, K | 1 |
| Masuyama, K | 1 |
1 other study available for suberoyl bis-hydroxamic acid and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Bindi | 2013 |